Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer.

Bekos, Christine; Grimm, Christoph; Kranawetter, Marlene; Polterauer, Stephan; Oberndorfer, Felicitas; Tan, Yen; Müllauer, Leonhard; Singer, Christian F.

Bekos C; Comprehensive Cancer Center, Gynecologic Cancer Unit, Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, A-1090 Vienna, Austria.
Grimm C; Comprehensive Cancer Center, Gynecologic Cancer Unit, Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, A-1090 Vienna, Austria.
Kranawetter M; Comprehensive Cancer Center, Gynecologic Cancer Unit, Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, A-1090 Vienna, Austria.
Polterauer S; Comprehensive Cancer Center, Gynecologic Cancer Unit, Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, A-1090 Vienna, Austria.
Oberndorfer F; Department of Pathology, Medical University of Vienna, A-1090 Vienna, Austria.
Tan Y; Comprehensive Cancer Center, Gynecologic Cancer Unit, Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, A-1090 Vienna, Austria.
Müllauer L; Department of Pathology, Medical University of Vienna, A-1090 Vienna, Austria.
Singer CF; Comprehensive Cancer Center, Gynecologic Cancer Unit, Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, A-1090 Vienna, Austria.

J Pers Med ; 11(7)2021 Jun 24.

Article en En | MEDLINE | ID: mdl-34202525